Jiangsu Lianhuan Pharmaceutical has reached its price limit, with Hualan Vaccine, New Ganjiang, Xiangxue Pharmaceutical, Sichuan Goldstone, and PKU HealthCare Corp. following suit. In terms of news, since the end of last year, many areas across the country have experienced a high incidence of H1N1 flu. According to the latest data from the Chinese Center for Disease Control and Prevention, the current positivity rate for influenza viruses continues to rise, with over 99% being Type A influenza (H1N1).
抗流感概念逆势活跃 联环药业涨停
Against Influenza Concept is actively thriving against the trend, Jiangsu Lianhuan Pharmaceutical hits the upper limit.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha